Available active surveillance follow-up protocols for small renal mass: a systematic review

ConclusionThe minimal cancer-specific mortality does not seem to correlate with the follow-up scheme. Outside of growth rate and initial size, imaging features to predict outcome of RCC during AS are limited. Active surveillance of SRM is a well-established treatment option. However, standardized follow-up protocols are lacking. Prospective, randomized, trials to evaluate the best follow-up strategies are pending.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research